Eric Halioua – President & CEO, PDC*line Pharma
PDC*line Pharma’s Eric Halioula explains why he decided to establish a biotech in Belgium, outlines the progress that his immuno-oncology focused firm has made in clinical trials since our last…
Address: Namur Office Park | Avenue des Dessus de Lives, 6 | B-5101 Loyers (Namur)
Tel: +32 81 33 28 50
Web: http://www.investinwallonia.be/?lang=en
Helping foreign investors to successfully set up and integrate their activities as part of the regional economic fabric.
The Foreign Investors division of the Agence Wallonne à l’Exportation et aux Investments étrangers (AWEX) (Walloon Exports and Foreign Investments Agency) is home to a multilingual team of expert consultants who are entirely at your service.
From an initial feasibility study all the way up to signing on the dotted line in concluding the investment, we provide personalised assistance geared to your needs and situation.
If you are a foreign investor looking to develop your activities in Wallonia, you can rest safe in the knowledge that our team of experts is there to assist you every step of the way.
Contact us!
Investor services : the point of single contact for all aspiring foreign investors seeking to set up business in Wallonia.
Our remit is:
to help you in seeking out appropriate sites and premises;to provide assistance with the start-up, development and diversification of your business;
to help you gain access to venture capital;
to provide advice and assistance in attracting suitable human resources;
to help you with setting up training programmes;
to provide assistance in obtaining subsidies from the Regional and European authorities;
to provide legal, tax and logistics support;
PDC*line Pharma’s Eric Halioula explains why he decided to establish a biotech in Belgium, outlines the progress that his immuno-oncology focused firm has made in clinical trials since our last…
Once primarily associated with dispensing medications alone, many pharmacies have now evolved into dynamic healthcare hubs, offering a diverse range of services that extend far beyond traditional prescription filling. Similarly,…
The concepts of patient-centricity and patient-centred healthcare systems have been much discussed in recent years but, in the opinion of Stefan Gijssels, there is still a long road to travel…
Pierre Boyer, GM at Servier BeLux for the past six years, outlines the unique characteristics and challenges of the Belgian market and shares the company’s 2030 strategy, its unique approach…
Gedeon Richter Benelux’s Isabelle de Walsche gives an update on the affiliate’s progress towards becoming a reference player in women’s health, looks back on some of her achievements over 11…
Luc Van Gorp is president of the Christian Mutuality, Belgium’s largest health insurance fund. In a wide-ranging recent conversation with PharmaBoardroom, Van Gorp expanded on some of the key themes…
Xavier De Cuyper of the Federal Agency for Medicines & Health Products (FAMHP), Belgium’s drug regulator, explains the FAMHP’s pandemic response and lessons learned, how the Agency is keeping on…
As part of the EU’s Pharmaceutical Strategy for Europe, the European Commission has come out with a set of proposals to revise EU pharmaceutical legislation. The reforms, which aim to…
Gábor Sztaniszláv talks through the global relevance of Belux to Amgen’s operations, some of the challenging market access conditions at play – especially for orphan drugs -, and how the…
Marc Gryseels of BACHI, Belgium’s over-the-counter (OTC) medicines association, highlights the organisation’s mission and vision, the key trends at play within the Belgian consumer healthcare market, and his industry’s significant…
Despite the thriving life sciences ecosystem that has made Belgium one of the top European destinations for clinical trials, the country continues to grapple with considerable access challenges and remains…
pharma.be is the association of the Belgian R&D-based pharmaceutical industry, representing over 42,000 employees at 130 companies. CEO Caroline Ven outlines the crucial role that pharma.be and its members played…
See our Cookie Privacy Policy Here